A Phase III Study of FE 999913 in Japanese Female Patients Undergoing Fertility Treatment

NCT01710514 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

108

Enrollment

INDUSTRY

Sponsor class

Conditions

Luteal Hormone Supplementation

Interventions

DRUG: FE 999913 vaginal tablet

Sponsor

Ferring Pharmaceuticals